Skip to content
LifeSci_Capital_2C_solid
  • Home
  • Expertise
    • Equity Research
    • Investment Banking
    • Equity Capital Markets
  • Team
  • LifeSci Platform
  • Careers
  • Contact
  • Home
  • Expertise
    • Equity Research
    • Investment Banking
    • Equity Capital Markets
  • Team
  • LifeSci Platform
  • Careers
  • Contact Us

Spyre Therapeutics

By Stephanie Gajdjis | April 20, 2026
Read More

Adagene

By Stephanie Gajdjis | April 20, 2026
Read More

Celldex Therapeutics

By Stephanie Gajdjis | April 20, 2026
Read More

Larimar Therapeutics

By Stephanie Gajdjis | April 20, 2026
Read More

Palvella Therapeutics

By Stephanie Gajdjis | April 20, 2026
Read More

Candel Therapeutics

By Stephanie Gajdjis | April 20, 2026
Read More

Eupraxia Pharmaceuticals

By Stephanie Gajdjis | April 20, 2026
Read More

Monte Rosa Therapeutics

By Stephanie Gajdjis | February 17, 2026
Read More

Praxis Precision Medicines

By Stephanie Gajdjis | February 17, 2026
Read More

Immunome

By Stephanie Gajdjis | December 17, 2025
Read More
Older Posts »
logo-color

LifeSci Capital is a boutique investment bank focused solely on emerging Life Science and Healthcare companies.

  • Home
  • Team
  • LifeSci Platform
  • Careers
  • Contact Us

Headquarters

1700 Broadway, 40th Floor

New York, NY 10019

+1 646 847 1400

info@lifescicapital.com

© 2026 LifeSci Capital. Business Continuity Plan  |  CIP Notification  |  Member: SIPC / FINRA  |  Disclosure 605 & 606 Reporting |  Privacy Policy